Advances in viral oncolytics for treatment of multiple myeloma – a focused review

Bovine pestivirus is a new alternative virus for multiple myeloma oncolytic virotherapy

(2020) Valentina Marchica et al.   Journal of Hematology & Oncology

Plasmacytoid dendritic cells orchestrate innate and adaptive anti-tumor immunity induced by oncolytic coxsackievirus A21

(2019) Louise M. E. Müller et al.   Journal for ImmunoTherapy of Cancer

Clinical Trials with Oncolytic Measles Virus: Current Status and Future Prospects

(2018) Pavlos Msaouel et al.   CURRENT CANCER DRUG TARGETS

Mesenchymal stem cells in multiple myeloma: a therapeutical tool or target?

(2018) Song Xu et al.   LEUKEMIA

Oncotargeting by Vesicular Stomatitis Virus (VSV): Advances in Cancer Therapy

(2018) Suman Bishnoi et al.   Viruses-Basel

Oncolytic Viruses for Multiple Myeloma Therapy

(2018) Christine Calton et al.   Cancers

Phase I trial of systemic administration of Edmonston strain of measles virus genetically engineered to express the sodium iodide symporter in patients with recurrent or refractory multiple myeloma

(2017) A Dispenzieri et al.   LEUKEMIA

Oncolytic virotherapy as an immunotherapeutic strategy for multiple myeloma

(2017) Daniel E. Meyers et al.   Blood Cancer Journal

Efficacy and Safety of Doubly-Regulated Vaccinia Virus in a Mouse Xenograft Model of Multiple Myeloma

(2017) Muneyoshi Futami et al.   Molecular Therapy-Oncolytics

Myxoma Virus Induces Ligand Independent Extrinsic Apoptosis in Human Myeloma Cells

(2016) Mee Y. Bartee et al.   Clinical Lymphoma Myeloma & Leukemia

Antibody-drug conjugate targeting CD46 eliminates multiple myeloma cells

(2016) Daniel W. Sherbenou et al.   JOURNAL OF CLINICAL INVESTIGATION

MicroRNA-Detargeted Mengovirus for Oncolytic Virotherapy

(2016) Autumn J. Ruiz et al.   JOURNAL OF VIROLOGY

Histone Deacetylase Inhibitors Enhance the Therapeutic Potential of Reovirus in Multiple Myeloma

(2016) A. Stiff et al.   MOLECULAR CANCER THERAPEUTICS

Systemic therapy with oncolytic myxoma virus cures established residual multiple myeloma in mice

(2016) Eric Bartee et al.   Molecular Therapy-Oncolytics

Combined expression of miR-34a and Smac mediated by oncolytic vaccinia virus synergistically promote anti-tumor effects in Multiple Myeloma

(2016) Wen Lei et al.   Scientific Reports

Vaccinia virus, a promising new therapeutic agent for pancreatic cancer

(2015) Chadwan Al Yaghchi et al.   Immunotherapy

A Phase I Trial of Single-Agent Reolysin in Patients with Relapsed Multiple Myeloma

(2014) D. W. Sborov et al.   CLINICAL CANCER RESEARCH

Endothelial JAM-A Promotes Reovirus Viremia and Bloodstream Dissemination

(2014) Caroline M. Lai et al.   JOURNAL OF INFECTIOUS DISEASES

Remission of Disseminated Cancer After Systemic Oncolytic Virotherapy

(2014) Stephen J. Russell et al.   MAYO CLINIC PROCEEDINGS

The Adenovirus Genome Contributes to the Structural Stability of the Virion

(2014) Bratati Saha et al.   Viruses-Basel

Oncolytic vesicular stomatitis virus and bortezomib are antagonistic against myeloma cells in vitro but have additive anti-myeloma activity in vivo

(2013) Danielle N. Yarde et al.   EXPERIMENTAL HEMATOLOGY

Selective Purging of Human Multiple Myeloma Cells from Autologous Stem Cell Transplantation Grafts using Oncolytic Myxoma Virus

(2012) Eric Bartee et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Potent systemic therapy of multiple myeloma utilizing oncolytic vesicular stomatitis virus coding for interferon-β

(2012) S Naik et al.   CANCER GENE THERAPY

Reovirus as a Viable Therapeutic Option for the Treatment of Multiple Myeloma

(2012) C. M. Thirukkumaran et al.   CLINICAL CANCER RESEARCH

Integrin  1 Mediates Vaccinia Virus Entry through Activation of PI3K/Akt Signaling

(2012) R. Izmailyan et al.   JOURNAL OF VIROLOGY

Curative one-shot systemic virotherapy in murine myeloma

(2012) S Naik et al.   LEUKEMIA

The encephalomyocarditis virus

(2012) Margot Carocci et al.   Virulence

Species D Adenoviruses as Oncolytics against B-cell Cancers

(2011) C. Y. Chen et al.   CLINICAL CANCER RESEARCH

Myeloma Xenograft Destruction by a Nonviral Vector Delivering Oncolytic Infectious Nucleic Acid

(2011) Elizabeth M Hadac et al.   MOLECULAR THERAPY

The Oncolytic Poxvirus JX-594 Selectively Replicates in and Destroys Cancer Cells Driven by Genetic Pathways Commonly Activated in Cancers

(2011) Kelley A Parato et al.   MOLECULAR THERAPY

Reovirus therapy stimulates endoplasmic reticular stress, NOXA induction and augments bortezomib-mediated apoptosis in multiple myeloma

(2011) K R Kelly et al.   ONCOGENE

Efficacy Assessment of Interferon-Alpha–Engineered Mesenchymal Stromal Cells in a Mouse Plasmacytoma Model

(2010) Silvia Sartoris et al.   STEM CELLS AND DEVELOPMENT

Growth Inhibition of Human Multiple Myeloma Cells by an Oncolytic Adenovirus Carrying the CD40 Ligand Transgene

(2009) M. S. Fernandes et al.   CLINICAL CANCER RESEARCH

Infection and Killing of Multiple Myeloma by Adenoviruses

(2009) Julien S. Senac et al.   HUMAN GENE THERAPY

The Interferon System and Vaccinia Virus Evasion Mechanisms

(2009) Beatriz Perdiguero et al.   JOURNAL OF INTERFERON AND CYTOKINE RESEARCH

Reovirus infection of cancer cells is not due to activated Ras pathway

(2008) L Song et al.   CANCER GENE THERAPY

Cell carriers to deliver oncolytic viruses to sites of myeloma tumor growth

(2008) A Munguia et al.   GENE THERAPY

Oncolytic virotherapy for multiple myeloma using a tumour-specific double-deleted vaccinia virus

(2008) H Deng et al.   LEUKEMIA

Engineering microRNA responsiveness to decrease virus pathogenicity

(2008) Elizabeth J Kelly et al.   NATURE MEDICINE